Regulation of Chronic Inflammation by Control of Macrophage Activation and Polarization

Chapter
First Online:

Abstract

Heterogeneity and plasticity are hallmarks of macrophages. Activated macrophages can be classified into two groups: M1 (or classically activated) and M2 (or alternatively activated) macrophages. Various pathological conditions have been associated with dynamic changes in the phenotypes of macrophages. Impaired polarization of macrophages affects the progression of several diseases including inflammation, tumour progression, and obesity-associated insulin resistance. Identification of the activation status of macrophages and regulations of macrophage polarization from M1 to M2 or vice versa, might serve as novel diagnostic or therapeutic approaches for various diseases. Many signalling molecules, transcription factors, epigenetic modifiers, and miRNAs (microRNAs) are known to regulate macrophage polarization and activation. Here we show that phosphatase and PTEN (phosphatase and tensin homologue deleted on chromosome 10) and SHIP1 (Src homology 2-containing inositol phosphatase 1), which dephosphorylate second messenger PtdIns(3,4,5)P3 (phosphatidylinositol 3,4,5-trisphosphate), can also act as regulators of macrophage polarization and activation. We compared Pten −/− macrophages and Ship1 −/− macrophages under similar conditions in vitro and in vivo and found that they regulate macrophage polarization by different mechanisms.

Keywords

Macrophage Activation Polarization PtdIns(3,4,5)P3 PTEN SHIP1 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This work was supported by Japan Science and Technology Agency (JST).

References

  1. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280–288CrossRefPubMedGoogle Scholar
  2. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655–1657CrossRefPubMedGoogle Scholar
  3. Cao X et al (2004) The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages. J Immunol 172:4851–4857CrossRefPubMedGoogle Scholar
  4. Chawla A (2010) Control of macrophage activation and function by PPARs. Circ Res 106:1559–1569CrossRefPubMedPubMedCentralGoogle Scholar
  5. Clark J et al (2011) Quantification of PtdInsP3 molecular species in cells and tissues by mass spectrometry. Nat Methods 8:267–272CrossRefPubMedPubMedCentralGoogle Scholar
  6. Cullen PJ, Venkateswarlu K (1999) Potential regulation of ADP-ribosylation factor 6 signalling by phosphatidylinositol 3,4,5-trisphosphate. Biochem Soc Trans 27:683–689CrossRefPubMedGoogle Scholar
  7. Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657CrossRefPubMedGoogle Scholar
  8. Franke TF (2008) Intracellular signaling by Akt: bound to be specific. Sci Signal 1:pe29CrossRefPubMedGoogle Scholar
  9. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35CrossRefPubMedGoogle Scholar
  10. Gordon S, Pluddemann A, Martinez Estrada F (2014) Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev 262:36–55CrossRefPubMedPubMedCentralGoogle Scholar
  11. Hadidi S et al (2012) Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection. Mucosal Immunol 5:535–543PubMedGoogle Scholar
  12. Helgason CD et al (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12:1610–1620CrossRefPubMedPubMedCentralGoogle Scholar
  13. Hill AA, Reid Bolus W, Hasty AH (2014) A decade of progress in adipose tissue macrophage biology. Immunol Rev 262:134–152CrossRefPubMedPubMedCentralGoogle Scholar
  14. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867CrossRefPubMedGoogle Scholar
  15. Itoh T, Takenawa T (2002) Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling. Cell Signal 14:733–743CrossRefPubMedGoogle Scholar
  16. Jinushi M, Komohara Y (2015) Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta 1855:123–130PubMedGoogle Scholar
  17. Kozicky LK, Sly LM (2015) Phosphatase regulation of macrophage activation. Semin Immunol 27:276–285CrossRefPubMedGoogle Scholar
  18. Krystal G (2000) Lipid phosphatases in the immune system. Semin Immunol 12:397–403CrossRefPubMedGoogle Scholar
  19. Kuroda S et al (2008) Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages. Eur J Immunol 38:1331–1340CrossRefPubMedGoogle Scholar
  20. Kuroda E et al (2011) SHIP represses Th2 skewing by inhibiting IL-4 production from basophils. J Immunol 186:323–332CrossRefPubMedGoogle Scholar
  21. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–761CrossRefPubMedGoogle Scholar
  22. Lee S et al (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22:317–326CrossRefPubMedPubMedCentralGoogle Scholar
  23. Liu G, Abraham E (2013) MicroRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol 33:170–177CrossRefPubMedPubMedCentralGoogle Scholar
  24. Liu Q et al (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 13:786–791CrossRefPubMedPubMedCentralGoogle Scholar
  25. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175–184CrossRefPubMedPubMedCentralGoogle Scholar
  26. Maehama T (2007) PTEN: its deregulation and tumorigenesis. Biol Pharm Bull 30:1624–1627CrossRefPubMedGoogle Scholar
  27. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555CrossRefPubMedGoogle Scholar
  28. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229:176–185CrossRefPubMedGoogle Scholar
  29. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483CrossRefPubMedGoogle Scholar
  30. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969CrossRefPubMedPubMedCentralGoogle Scholar
  31. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737CrossRefPubMedPubMedCentralGoogle Scholar
  32. Neele AE, Van den Bossche J, Hoeksema MA, de Winther MP (2015) Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur J Pharmacol 763:79–89CrossRefPubMedGoogle Scholar
  33. Odegaard JI, Chawla A (2011) Alternative macrophage activation and metabolism. Annu Rev Pathol 6:275–297CrossRefPubMedPubMedCentralGoogle Scholar
  34. Ooms LM et al (2009) The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 419:29–49CrossRefPubMedGoogle Scholar
  35. Porta C et al (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106:14978–14983CrossRefPubMedPubMedCentralGoogle Scholar
  36. Rauh MJ et al (2005) SHIP represses the generation of alternatively activated macrophages. Immunity 23:361–374CrossRefPubMedGoogle Scholar
  37. Sahin E et al (2014) Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol 193:1717–1727CrossRefPubMedPubMedCentralGoogle Scholar
  38. Sasaki T, Sasaki J, Sakai T, Takasuga S, Suzuki A (2007) The physiology of phosphoinositides. Biol Pharm Bull 30:1599–1604CrossRefPubMedGoogle Scholar
  39. Sasaki T et al (2009) Mammalian phosphoinositide kinases and phosphatases. Prog Lipid Res 48:307–343CrossRefPubMedGoogle Scholar
  40. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122:787–795CrossRefPubMedPubMedCentralGoogle Scholar
  41. Sica A et al (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18:349–355CrossRefPubMedGoogle Scholar
  42. Sly LM et al (2009) SHIP prevents lipopolysaccharide from triggering an antiviral response in mice. Blood 113:2945–2954CrossRefPubMedPubMedCentralGoogle Scholar
  43. Stephens L, Milne L, Hawkins P (2008) Moving towards a better understanding of chemotaxis. Curr Biol 18:R485–R494CrossRefPubMedGoogle Scholar
  44. Suzuki A, Nakano T, Mak TW, Sasaki T (2008) Portrait of PTEN: messages from mutant mice. Cancer Sci 99:209–213CrossRefPubMedGoogle Scholar
  45. Takeda N et al (2010) Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev 24:491–501CrossRefPubMedPubMedCentralGoogle Scholar
  46. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11:329–341CrossRefPubMedGoogle Scholar
  47. Waidmann O et al (2013) Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. J Hepatol 59:769–779CrossRefPubMedGoogle Scholar
  48. Welch HC (2015) Regulation and function of P-Rex family Rac-GEFs. Small GTPases 6:49–70CrossRefPubMedPubMedCentralGoogle Scholar
  49. Wymann MP, Pirola L (1998) Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta 1436:127–150CrossRefPubMedGoogle Scholar
  50. Yue S et al (2014) Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. J Immunol 192:5343–5353CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  1. 1.Department of Medical BiologyAkita University Graduate School of MedicineAkitaJapan
  2. 2.PRESTOJapan Science and Technology AgencyKawaguchiJapan
  3. 3.Research Center for BiosignalAkita UniversityAkitaJapan

Personalised recommendations